Clinical

share

Roche announced results from the global phase III ALUR study showing that Alecensa® significantly reduced the risk of...

share

Midatech Pharma has announced the submission of a clinical trial application (CTA) for a first in human study...

share

ViraCyte, LLC, a clinical stage biopharmaceutical company developing cellular immunotherapies for severe infections, announced publication of positive data...

share

Eli Lilly and Company has entered into a settlement agreement with generic companies to resolve pending patent litigation...

share

BioLight Life Sciences announced successful results from its glaucoma insert VS101 (“Eye-D latanoprost insert”) Phase 1/2a clinical trial, which...

share

Brainstorm Cell Therapeutics announced that the California Institute for Regenerative Medicine (CIRM) has awarded Brainstorm a grant of $16 million to support...

share

PharmaMar announced the start of a multicenter quadruple combination clinical study with Aplidin (plitidepsina), along with other compounds...

share

Flex Pharma has initiated a Phase 2 randomized, controlled, double-blinded, parallel design trial in the US. The COMMEND...